Thyroid Disorder Among Lean and Obese Polycystic Ovary Syndrome Phenotypes

    February 2021 in “ PARIPEX INDIAN JOURNAL OF RESEARCH
    Priya Agarwal, Varuna Pathak, Tripti Saxena
    Image of study
    TLDR Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.
    The study, conducted on 89 females with polycystic ovary syndrome (PCOS) and 93 non-PCOS females, found a higher prevalence of hypothyroidism in the PCOS group (21.34%) compared to the non-PCOS group (8.6%). Within the PCOS group, obese females had a significantly higher prevalence of hypothyroidism (33.33%) and higher mean serum thyroid-stimulating hormone (TSH) levels (3.8 mIU/L) than lean PCOS females (10.67% prevalence of hypothyroidism and 2.14 mIU/L mean serum TSH). The study concluded that females with PCOS, especially those who are obese, are more likely to have hypothyroidism than non-PCOS females.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 44 results

      community C’est terrible - at my wits end

      in Female  446 upvotes 10 months ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Related Research

    3 / 3 results